Evidence map›Paper›PMID 35013095›Full record

ArticleTranslational psychiatry2022

mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [

Cláudia Régio Brambilla, Tanja Veselinović, Ravichandran Rajkumar, Jörg Mauler, Andreas Matusch, Andrej Ruch, Linda Orth, Shukti Ramkiran, Hasan Sbaihat, Nicolas Kaulen and 17 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 3 institutions in 2 countries.

Cláudia Régio BrambillaInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany. c.regio.brambilla@fz-juelich.de.ORCID http://orcid.org/0000-0002-3735-8511
Tanja VeselinovićDepartment of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, Germany.ORCID http://orcid.org/0000-0001-7906-6966
Ravichandran RajkumarInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0001-5875-5316
Jörg MaulerInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0003-4937-0355
Andreas MatuschInstitute of Neuroscience and Medicine, INM-2, Forschungszentrum Jülich GmbH, Jülich, Germany.
Andrej RuchDepartment of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, Germany.ORCID http://orcid.org/0000-0002-0524-347X
Linda OrthDepartment of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, Germany.ORCID http://orcid.org/0000-0003-0733-9624
Shukti RamkiranInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0001-8253-1873
Hasan SbaihatInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0003-4973-3195
Nicolas KaulenDepartment of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, Germany.
Nibal Yahya KhudeishInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.
Christine WyssDepartment of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-2088-9794
Karsten HeekerenDepartment of Psychiatry and Psychotherapy I, LVR-Hospital, Cologne, Germany.ORCID http://orcid.org/0000-0001-5105-1922
Wolfram KawohlDepartment of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry, Zurich, Switzerland.
Elena Rota KopsInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0002-0959-9457
Lutz TellmannInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0002-1154-2847
Jürgen ScheinsInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0003-3474-430X
Frank BoersInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0001-7552-4931
Bernd NeumaierInstitute of Neuroscience and Medicine, INM-5, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0001-5425-3116
Johannes ErmertInstitute of Neuroscience and Medicine, INM-5, Forschungszentrum Jülich GmbH, Jülich, Germany.
Markus LangInstitute of Neuroscience and Medicine, INM-5, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0002-6837-790X
Stefan StüsgenInstitute of Neuroscience and Medicine, INM-5, Forschungszentrum Jülich GmbH, Jülich, Germany.
Hans HerzogInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0002-6751-7165
Karl-Josef LangenInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0003-1101-5075
N Jon ShahInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0002-8151-6169
Christoph W Lerche *Institute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0003-2749-2108
Irene Neuner *Institute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID http://orcid.org/0000-0002-5164-8873
Forschungszentrum Jülich · DERWTH Aachen University · DEUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, the metabotropic glutamate receptor 5 (mGluR5) is the subject of several lines of research in the context of neurology and is of high interest as a target for positron-emission tomography (PET). Here, we assessed the feasibility of using [

Indexed as

Positron-Emission TomographyReceptor, Metabotropic Glutamate 5Carbon RadioisotopesElectroencephalographyHumansOximesPyridines3-(6-methylpyridin-2-ylethynyl)cyclohex-2-enone-O-methyloximeCarbon RadioisotopesGRM5 protein, humanOximesPyridinesReceptor, Metabotropic Glutamate 5

Identifiers

PMID35013095
PMCPMC8748790
OpenAlexW4205151802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.